Find Reports
Select Report Type
Reimbursement Review
Displaying 1126 - 1150 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| ataluren | Translarna | ataluren | Cancelled | SR0607-000 | |||||
| Abiraterone (Zytiga) for Prost... | Zytiga (Resubmission) | Abiraterone | Prostate Cancer Resubmission | Withdrawn | PC0201-000 | ||||
| Entrectinib (TBD) for Neurotro... | TBD | Entrectinib | Withdrawn | PC0157-000 | |||||
| Nelarabine for Acute Lymphobla... | Atriance | Nelarabine | Cancelled | PC0170-000 | |||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| ravulizumab | TBC | ravulizumab | Paroxysmal nocturnal hemoglobinuria. | Withdrawn | SR0623-000 | ||||
| decitabine | Demylocan | decitabine | Myelodysplastic Syndromes | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0001-000 | |||
| RFA: Bosulif for Chronic Myelo... | Bosulif (RFA) | Bosutinib | Chronic Myeloid Leukemia | N/A | Complete | PA0002-000 | |||
| Trastuzumab for Breast and Gas... | TBD | Trastuzumab | Cancelled | PC0160-000 | |||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| Rituximab (Truxima) for Non-Ho... | Truxima | Rituximab | Cancelled | PC0184-000 | |||||
| pegaspargase | Oncaspar | pegaspargase | Adult Acute Lymphocytic Leukemia (ALL) | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0002-000 | |||
| ibritumomab tiuxetan | Zevalin | iIbritumomab tiuxetan | Non-Hodgkin’s Lymphoma (NHL) | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0003-000 | |||
| anakinra | Kineret | anakinra | Still's disease | Withdrawn | SR0662-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| filgotinib | TBC | filgotinib | Arthritis, Rheumatoid | Withdrawn | SR0656-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| CADTH Pharmaceutical Reviews U... | Pending | ||||||||
| Pharmaceutical Reviews Update ... | |||||||||
| lecanemab | Leqembi | lecanemab | Alzheimer’s disease | Suspended | SR0822-000 | ||||
| Endometrial Cancer | Endometrial Cancer | Complete | PH0045-000 | ||||||
| NSCLC without actionable oncog... | NSCLC without actionable oncogenic alteration | Complete | PH0046-000 | ||||||
| Ibrance for Advanced Breast Ca... | Ibrance | Palbociclib | Withdrawn | PC0068-000 | |||||
| Adult Classical Hodgkin Lympho... | Adult Classical Hodgkin Lymphoma | Complete | PH0052-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1126 - 1150 of 2132
Please scroll or swipe to the right to view the full content.